Snisarenko John

CIK 00017832642 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001783264

Recent Transactions

20 trades

Disposition to Issuer
ALIMERA SCIENCES INC
Stock Option (Right to Buy)
2024-09-16−3,333→ 0 total
Disposition to Issuer
ALIMERA SCIENCES INC
Common Stock
2024-09-16−10,000→ 0 total
Disposition to Issuer
ALIMERA SCIENCES INC
Stock Option (Right to Buy)
2024-09-16−46,150→ 0 total
Disposition to Issuer
ALIMERA SCIENCES INC
Stock Option (Right to Buy)
2024-09-16−50,000→ 0 total
Disposition to Issuer
ALIMERA SCIENCES INC
Stock Option (Right to Buy)
2024-09-16−6,000→ 0 total
Disposition to Issuer
ALIMERA SCIENCES INC
Stock Option (Right to Buy)
2024-09-16−6,000→ 0 total
Award
ALIMERA SCIENCES INC
Stock Option (Right to Buy)
2023-10-02+50,000→ 50,000 total
Award
ALIMERA SCIENCES INC
Stock Option (Right to Buy)
2023-01-04+6,000→ 6,000 total
Award
Oyster Point Pharma, Inc.
Common Stock
2022-01-09+12,100→ 30,322 total
Award
Oyster Point Pharma, Inc.
Employee Stock Option (Right to Buy)
2022-01-09+54,500→ 54,500 total
Award
ALIMERA SCIENCES INC
Stock Option (Right to Buy)
2021-11-02+6,000→ 6,000 total
Award
Oyster Point Pharma, Inc.
Employee Stock Option (Right to Buy)
2021-09-22+20,000→ 20,000 total
Award
Oyster Point Pharma, Inc.
Common Stock
2021-01-29+11,222→ 18,222 total
Award
Oyster Point Pharma, Inc.
Employee Stock Option (Right to Buy)
2021-01-29+50,500→ 50,500 total
Purchase
Oyster Point Pharma, Inc.
Common Stock
2020-08-10$25.97/sh+4,000→ 7,000 total
Award
ALIMERA SCIENCES INC
Stock Option (Right to Buy)
2020-06-18+3,333→ 3,333 total
Award
Oyster Point Pharma, Inc.
Employee Stock Option (Right to Buy)
2020-02-03+72,648→ 72,648 total
Purchase
ALIMERA SCIENCES INC
Common Stock
2019-11-21$4.95/sh+10,000→ 10,000 total
Purchase
Oyster Point Pharma, Inc.
Common Stock, par value $0.001 per share
2019-11-04$16.00/sh+3,000→ 3,000 total
Award
ALIMERA SCIENCES INC
Stock Option (Right to Buy)
2019-07-18+46,150→ 46,150 total

Companies

Recent Filings

Address

C/O OYSTER POINT PHARMA, INC. 202 CARNEGIE CENTER, SUITE 109

PRINCETON, NJ, 08540

View on SEC.gov